ORIC logo

ORIC Pharmaceuticals (ORIC) Company Overview

Profile

Full Name:

ORIC Pharmaceuticals, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

April 24, 2020

Indexes:

Not included

Description:

ORIC Pharmaceuticals is a biotechnology company focused on developing innovative cancer treatments. They aim to improve patient outcomes by targeting specific cancer mechanisms. Their research includes creating therapies that can overcome resistance to existing treatments, helping to provide more effective options for patients with various types of cancer.

Events Calendar

Earnings

Next earnings date:

May 6, 2025

Recent quarterly earnings:

Feb 19, 2025

Recent annual earnings:

Feb 19, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Feb 24, 25 HC Wainwright & Co.
Buy
Feb 21, 25 HC Wainwright & Co.
Buy
Feb 11, 25 HC Wainwright & Co.
Buy
Feb 10, 25 Guggenheim
Buy
Feb 6, 25 JP Morgan
Overweight
Jan 14, 25 Cantor Fitzgerald
Overweight
Jan 13, 25 HC Wainwright & Co.
Buy
Nov 4, 24 HC Wainwright & Co.
Buy
Oct 31, 24 Wells Fargo
Overweight
Oct 31, 24 Jones Trading
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for ORIC Pharmaceuticals?
  • Does ORIC Pharmaceuticals pay dividends?
  • What sector is ORIC Pharmaceuticals in?
  • What industry is ORIC Pharmaceuticals in?
  • What country is ORIC Pharmaceuticals based in?
  • When did ORIC Pharmaceuticals go public?
  • Is ORIC Pharmaceuticals in the S&P 500?
  • Is ORIC Pharmaceuticals in the NASDAQ 100?
  • Is ORIC Pharmaceuticals in the Dow Jones?
  • When was ORIC Pharmaceuticals's last earnings report?
  • When does ORIC Pharmaceuticals report earnings?
  • Should I buy ORIC Pharmaceuticals stock now?

What is the ticker symbol for ORIC Pharmaceuticals?

The ticker symbol for ORIC Pharmaceuticals is NASDAQ:ORIC

Does ORIC Pharmaceuticals pay dividends?

No, ORIC Pharmaceuticals does not pay dividends

What sector is ORIC Pharmaceuticals in?

ORIC Pharmaceuticals is in the Healthcare sector

What industry is ORIC Pharmaceuticals in?

ORIC Pharmaceuticals is in the Biotechnology industry

What country is ORIC Pharmaceuticals based in?

ORIC Pharmaceuticals is headquartered in United States

When did ORIC Pharmaceuticals go public?

ORIC Pharmaceuticals's initial public offering (IPO) was on April 24, 2020

Is ORIC Pharmaceuticals in the S&P 500?

No, ORIC Pharmaceuticals is not included in the S&P 500 index

Is ORIC Pharmaceuticals in the NASDAQ 100?

No, ORIC Pharmaceuticals is not included in the NASDAQ 100 index

Is ORIC Pharmaceuticals in the Dow Jones?

No, ORIC Pharmaceuticals is not included in the Dow Jones index

When was ORIC Pharmaceuticals's last earnings report?

ORIC Pharmaceuticals's most recent earnings report was on Feb 19, 2025

When does ORIC Pharmaceuticals report earnings?

The next expected earnings date for ORIC Pharmaceuticals is May 6, 2025

Should I buy ORIC Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions